15 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
27
Design and synthesis of inhibitors of Plasmodium falciparum N-myristoyltransferase, a promising target for antimalarial drug discovery.

Imperial College
2
Crystal structures of Saccharomyces cerevisiae N-myristoyltransferase with bound myristoyl-CoA and inhibitors reveal the functional roles of the N-terminal region.

Chinese Academy of Sciences
35
Conformationally constrained [p-(omega-aminoalkyl)phenacetyl]-L-seryl-L-lysyl dipeptide amides as potent peptidomimetic inhibitors of Candida albicans and human myristoyl-CoA:protein N-myristoyl transferase.

G. D. Searle Research and Development
24
Discovery of a novel class of orally active trypanocidal N-myristoyltransferase inhibitors.

University of Dundee
21
Exploring N-myristoyltransferase as a promising drug target against parasitic neglected tropical diseases.

State University of Paraiba
47
3D-QSAR and molecular docking studies on benzothiazole derivatives as Candida albicans N-myristoyltransferase inhibitors.

Second Military Medical University
11
How To Design Selective Ligands for Highly Conserved Binding Sites: A Case Study Using

Johannes Gutenberg-Universit£T Mainz
5
Novel biologically active nonpeptidic inhibitors of myristoylCoA:protein N-myristoyltransferase.

G.D. Searle And
32
Design and synthesis of high affinity inhibitors of Plasmodium falciparum and Plasmodium vivax N-myristoyltransferases directed by ligand efficiency dependent lipophilicity (LELP).

Imperial College
5
Emerging New Targets for the Treatment of Resistant Fungal Infections.

Second Military Medical University
21
Interrogating the Roles of Post-Translational Modifications of Non-Histone Proteins.

Temple University
157
PYRIMIDINE COMPOUND AS WEE-1 INHIBITOR

Wigen Biomedicine Technology (Shanghai)
8
Peptidomimetic 2-cyanopyrrolidines as potent selective cathepsin L inhibitors.

The M. S. University of Baroda
26
Structural optimization of thiol-based inhibitors of glutamate carboxypeptidase II by modification of the P1' side chain.

Mgi Pharma